In Vitro Diagnostics (IVD) Quality Control Market - Global Forecast to 2030
商品番号 : SMB-5987
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 379 |
| 図表数 | 477 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
体外診断（IVD）品質管理市場 – 製品とサービス [QC（血漿、血清、血液）、ソリューション]、技術（免疫測定、MDx、微生物学、血液学）、メーカー（サードパーティ、OEM）、エンドユーザー（病院、研究所） – 2030年までの世界予測
この調査レポートでは、体外診断（IVD）品質管理市場を、製品とサービス（品質管理製品、データ管理ソリューション、品質保証サービス）、技術（免疫測定法、臨床化学、分子診断、微生物学、血液学、凝固および止血、その他の技術）、メーカータイプ（サードパーティ管理（独立管理、機器固有の管理、OEM管理）、エンドユーザー（病院、臨床検査室、学術研究機関、その他のエンドユーザー）、地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東およびアフリカ）別に分類しています。
本レポートは、体外診断（IVD）品質管理市場の成長に影響を与える主要な要因（促進要因、制約要因、機会、課題など）に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、各社の事業概要、ソリューション、主要戦略、買収、契約に関する洞察を提供しています。また、IVD品質管理市場エコシステムにおける新興企業の競合分析も含まれています。
本レポートは、体外診断（IVD）品質管理市場全体および各サブセグメントの収益数値の近似値に関する情報を提供し、市場リーダーおよび新規参入企業にとって役立ちます。また、関係者が競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、関係者が市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供するのに役立ちます。
体外診断（IVD）品質管理市場は、2025年に16億5,000万米ドルに達すると推定され、予測期間中に5.5％のCAGRで成長し、2030年までに21億5,000万米ドルに達すると予測されています。
体外診断（IVD）品質管理は、臨床検査室や医療施設における診断検査結果の正確性、信頼性、一貫性を確保する上で重要な役割を果たしています。サードパーティ製品質管理の導入拡大は、IVD品質管理市場の主要な推進力の一つです。機器固有の管理とは異なり、サードパーティ製ソリューションは、より高い柔軟性、複数のプラットフォーム間の互換性、そしてより長い保存期間を提供します。これらは、偏りのない性能評価と一貫した分析対象物の安定性を提供し、検査室が再現性と信頼性の高い結果を維持するのに役立ちます。規制および認定要件の強化に伴い、検査室はコンプライアンスを確保しながらワークフローの効率を最適化するために、サードパーティ製管理を採用しています。多検体管理の利用拡大は、複数のアッセイの同時モニタリングを可能にし、運用コストを削減することで、需要をさらに高めています。特に病院や臨床検査室は、大量検査と多様な診断アプリケーションをサポートするために、これらのソリューションを導入しています。サードパーティ製品質管理へのこうした移行は、世界の体外診断（IVD）品質管理市場におけるイノベーション、導入、そして持続的な成長を促進し続けています。
The IVD quality controls market is valued at an estimated USD 1.65 billion in 2025 and is projected to reach USD 2.15 billion by 2030, at a CAGR of 5.5% during the forecast period.
IVD quality controls play a critical role in ensuring the accuracy, reliability, and consistency of diagnostic test results across clinical laboratories and healthcare facilities. The growing adoption of third-party quality controls is one of the major drivers of the IVD quality controls market. Unlike instrument-specific controls, third-party solutions offer greater flexibility, compatibility across multiple platforms, and longer shelf life. They provide unbiased performance assessment and consistent analyte stability, helping laboratories maintain reproducible and reliable results. With increasing regulatory and accreditation requirements, laboratories are favoring third-party controls to ensure compliance while optimizing workflow efficiency. The rising use of multianalyte controls further enhances demand, allowing simultaneous monitoring of multiple assays and reducing operational costs. Hospitals and clinical laboratories, in particular, are adopting these solutions to support high-volume testing and diverse diagnostic applications. This shift toward third-party quality controls continues to drive innovation, adoption, and sustained growth in the global IVD quality controls market.
“By product & service, the quality control products segment dominated the IVD quality controls market in 2024.”
By product & service, the IVD quality controls market is segmented into quality control products, data management solutions, and quality assurance services. In 2024, quality control products held the largest share, driven by the increasing number of diagnostic tests and the need for accurate, reliable, and reproducible results. Regulatory and accreditation requirements further support their adoption, as laboratories aim to maintain compliance and ensure patient safety. Quality control products enable consistent performance monitoring across multiple assays and platforms, helping reduce errors and improve workflow efficiency. The rising use of third-party and multianalyte controls has further strengthened this segment, allowing simultaneous testing of multiple analytes while optimizing operational costs. Overall, QC products remain the backbone of laboratory quality management, making them the dominant segment within the IVD quality controls market.
“By manufacturer type, the third-party controls segment is projected to achieve the highest growth during the forecast period.”
By manufacturer type, the IVD quality controls market is segmented into third-party controls and original equipment manufacturer (OEM) controls. Third-party controls are projected to be the fastest-growing segment during the forecast period. Their compatibility across multiple platforms, longer shelf life, and unbiased performance assessment make them increasingly preferred by laboratories. Third-party controls also support multianalyte testing and standardized QC procedures, helping laboratories improve workflow efficiency and ensure reproducible results. While OEM controls remain important for instrument-specific applications, the growing demand for versatile, cost-effective, and reliable solutions continues to drive the rapid adoption of third-party controls globally.
“The Asia Pacific is projected to be the fastest-growing regional market during the forecast period.”
The market for IVD quality controls is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is anticipated to be the fastest-growing region in the IVD quality controls market during the forecast period, driven by the rapid development of healthcare infrastructure and increasing investment in advanced diagnostic technologies. The region is witnessing a growing number of clinical laboratories, hospitals, and diagnostic centers, which is boosting the demand for reliable and accurate quality control products. Rising awareness about the importance of early disease detection, coupled with regulatory initiatives to improve laboratory standards, is further supporting market growth. Additionally, the expanding patient population and the rising prevalence of chronic and infectious diseases are creating strong demand for quality control solutions to ensure accuracy and reproducibility.
Breakdown of the profiles of primary participants in the IVD quality controls market:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%)
- By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
The key players in the IVD quality controls market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott (US), LGC Limited (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Randox Laboratories Ltd. (UK), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (US), Danaher Corporation (US), Sysmex Corporation (Japan), Bio-Techne Corporation (US), Microbix Biosystems Inc. (Canada), Microbiologics, Inc. (US), ZeptoMetrix (US), Fortress Diagnostics (UK), Helena Laboratories Corporation (US), Streck, Inc. (US), SERO AS (Norway), Maine Molecular Quality Controls, Inc. (US), Sun Diagnostics, LLC (US), Alpha-Tec (US), Grifols, S.A. (Spain), ConeBioproducts (US), Eurotrol B.V. (Netherlands), and Biorex Diagnostics (UK).
Research Coverage:
This research report categorizes the IVD quality controls market by product & service (quality control products, data management solutions, and quality assurance services), technology (immunoassays, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation & hemostasis, and other technologies), manufacturer type [third-party controls ([independent controls, instrument-specific controls), original equipment manufacturer controls], end user (hospitals, clinical laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the IVD quality controls market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. A competitive analysis of upcoming startups in the IVD quality controls market ecosystem is covered in this report.
Reasons to Buy this Report:
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD quality controls market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, rising demand for external quality assessment support, rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, and increasing adoption of PoC instruments in developed regions), opportunities (rising demand for multianalyte controls and increasing growth opportunities in emerging economies), restraints (additional costs and budget constraints in hospitals and laboratories and unfavorable reimbursement scenario for IVD tests), and challenges (stringent product approval process and lack of regulations for clinical laboratory accreditation in several emerging countries) influencing the growth of the IVD quality controls market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the IVD quality controls market
- Market Development: Comprehensive information about lucrative markets across varied regions
- Market Diversification: Exhaustive information about products, untapped geographies, recent developments, and investments in the IVD quality controls market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott (US), LGC Limited (UK), and F. Hoffmann-La Roche Ltd. (Switzerland)
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKETS COVERED & REGIONAL SCOPE 35
1.4 INCLUSIONS & EXCLUSIONS 36
1.4.1 YEARS CONSIDERED 37
1.5 CURRENCY CONSIDERED 37
1.6 KEY STAKEHOLDERS 37
1.7 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.2 RESEARCH APPROACH 39
2.2.1 SECONDARY DATA 40
2.2.1.1 Key secondary sources 40
2.2.1.2 Key data from secondary sources 41
2.2.2 PRIMARY DATA 42
2.2.2.1 Primary sources 42
2.2.2.2 Key data from primary sources 43
2.2.2.3 Key industry insights 44
2.2.2.4 Breakdown of primary interviews 44
2.3 MARKET SIZE ESTIMATION 45
2.3.1 BOTTOM-UP APPROACH 45
2.3.1.1 Approach 1: Company revenue estimation approach 46
2.3.1.2 Approach 2: Presentations of companies and primary interviews 46
2.3.1.3 Growth forecast 46
2.3.1.4 CAGR projections 47
2.3.2 TOP-DOWN APPROACH 47
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 49
2.5 MARKET SHARE ASSESSMENT 49
2.6 RESEARCH ASSUMPTIONS 50
2.6.1 PARAMETRIC ASSUMPTIONS 50
2.7 RESEARCH LIMITATIONS 50
2.8 RISK ASSESSMENT 51
3 EXECUTIVE SUMMARY 52
4 PREMIUM INSIGHTS 56
4.1 IVD QUALITY CONTROLS MARKET OVERVIEW 56
4.2 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 57
4.3 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2025 VS. 2030 57
4.4 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2025 VS. 2030 58
4.5 IVD QUALITY CONTROLS MARKET, BY END USER, 2025 VS. 2030 58
4.6 IVD QUALITY CONTROLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 61
5.2.1.1 Increasing number of accredited clinical laboratories 61
5.2.1.2 Growing adoption of third-party quality controls 62
5.2.1.3 Rising demand for external quality assessment support 62
5.2.1.4 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases 63
5.2.1.5 Increasing adoption of POC instruments in developed regions 64
5.2.2 RESTRAINTS 65
5.2.2.1 Additional costs and budget constraints in hospitals and laboratories 65
5.2.2.2 Unfavorable reimbursement scenario for IVD tests 65
5.2.3 OPPORTUNITIES 66
5.2.3.1 Rising demand for multianalyte controls 66
5.2.3.2 Increasing growth opportunities in emerging economies 66
5.2.4 CHALLENGES 67
5.2.4.1 Stringent product approval process 67
5.2.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries 67
5.3 PRICING ANALYSIS 68
5.3.1 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS, 2023–2025 68
5.3.2 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROLS, BY KEY PLAYER, 2023–2025 68
5.3.3 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS,
BY REGION, 2023–2025 70
5.4 PATENT ANALYSIS 71
5.4.1 LIST OF MAJOR PATENTS 72
5.5 VALUE CHAIN ANALYSIS 73
5.6 SUPPLY CHAIN ANALYSIS 74
5.7 TRADE ANALYSIS 75
5.7.1 IMPORT DATA (HS CODE 3822) 76
5.7.2 EXPORT DATA (HS CODE 3822) 76
5.8 ECOSYSTEM ANALYSIS 77
5.8.1 IVD QUALITY CONTROLS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 78
5.9 PORTER’S FIVE FORCES ANALYSIS 79
5.9.1 THREAT OF NEW ENTRANTS 80
5.9.2 THREAT OF SUBSTITUTES 80
5.9.3 BARGAINING POWER OF BUYERS 80
5.9.4 BARGAINING POWER OF SUPPLIERS 80
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.10 REGULATORY ANALYSIS 81
5.10.1 REGULATORY FRAMEWORK 81
5.10.1.1 North America 81
5.10.1.1.1 US 81
5.10.1.1.2 Canada 82
5.10.1.2 Europe 83
5.10.1.2.1 Germany 84
5.10.1.2.2 UK 84
5.10.1.2.3 France 85
5.10.1.2.4 Italy 85
5.10.1.3 Asia Pacific 85
5.10.1.3.1 China 85
5.10.1.3.2 Japan 85
5.10.1.3.3 India 86
5.10.1.4 Latin America 87
5.10.1.4.1 Brazil 87
5.10.1.4.2 Mexico 87
5.10.1.5 Middle East 88
5.10.1.6 Africa 88
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
5.11 TECHNOLOGY ANALYSIS 90
5.11.1 KEY TECHNOLOGIES 91
5.11.1.1 Immunoassays 91
5.11.2 COMPLEMENTARY TECHNOLOGIES 91
5.11.2.1 Molecular diagnostics 91
5.11.3 ADJACENT TECHNOLOGIES 92
5.11.3.1 Clinical chemistry 92
5.12 KEY CONFERENCES & EVENTS, 2025–2026 92
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 94
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
5.14.2 BUYING CRITERIA 94
5.15 INVESTMENT & FUNDING SCENARIO 95
5.16 CASE STUDY ANALYSIS 96
5.16.1 CASE STUDY 1: QUALITY CONTROL DATA MANAGEMENT WITH UNITY
REAL-TIME IN MOLECULAR VIROLOGY 96
5.16.2 CASE STUDY 2: ENHANCING RELIABILITY OF INFLUENZA DIAGNOSTICS WITH EXTERNAL QUALITY CONTROLS 96
5.17 IMPACT OF AI/GENERATIVE AI ON IVD QUALITY CONTROLS MARKET 97
5.17.1 INTRODUCTION 97
5.17.2 MARKET POTENTIAL OF AI 97
5.17.3 AI USE CASES 98
5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY AND USE CASE 99
5.17.5 FUTURE OF AI IN IVD QUALITY CONTROLS MARKET 99
5.18 IMPACT OF 2025 US TARIFFS ON IVD QUALITY CONTROLS MARKET 99
5.18.1 INTRODUCTION 99
5.18.2 KEY TARIFF RATES 100
5.18.3 PRICE IMPACT ANALYSIS 100
5.18.4 IMPACT ON COUNTRY/REGION 101
5.18.4.1 North America 101
5.18.4.2 Europe 101
5.18.4.3 Asia Pacific 101
5.18.5 IMPACT ON END-USE INDUSTRIES 101
5.18.5.1 Hospitals 101
5.18.5.2 Clinical laboratories 102
5.18.5.3 Academic & research institutes 102
6 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE 103
6.1 INTRODUCTION 104
6.2 QUALITY CONTROL PRODUCTS 104
6.2.1 SERUM/PLASMA-BASED CONTROLS 108
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase demand for serum/plasma-based controls 108
6.2.2 WHOLE BLOOD-BASED CONTROLS 112
6.2.2.1 Rising need to ensure high-quality clinical test results to drive market 112
6.2.3 URINE-BASED CONTROLS 115
6.2.3.1 Growing incidence of kidney diseases to drive demand for urine-based controls 115
6.2.4 OTHER CONTROLS 119
6.3 DATA MANAGEMENT SOLUTIONS 123
6.3.1 RISING FOCUS ON IMPROVING ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH 123
6.4 QUALITY ASSURANCE SERVICES 126
6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE DEMAND FOR QUALITY ASSURANCE SERVICES 126
7 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY 129
7.1 INTRODUCTION 130
7.2 IMMUNOASSAYS 130
7.2.1 FOCUS ON MONITORING PRECISION OF IMMUNOASSAY TESTS TO DRIVE ADOPTION OF IMMUNOASSAY CONTROLS 130
7.3 CLINICAL CHEMISTRY 134
7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH 134
7.4 MOLECULAR DIAGNOSTICS 138
7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS 138
7.5 MICROBIOLOGY 142
7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH 142
7.6 HEMATOLOGY 146
7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS 146
7.7 COAGULATION & HEMOSTASIS 150
7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE DEMAND FOR COAGULATION & HEMOSTASIS TESTING 150
7.8 OTHER TECHNOLOGIES 153
8 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE 157
8.1 INTRODUCTION 158
8.2 THIRD-PARTY CONTROLS 158
8.2.1 INDEPENDENT CONTROLS 162
8.2.1.1 Unbiased and independent performance assessment for analytical processes to drive adoption 162
8.2.2 INSTRUMENT-SPECIFIC CONTROLS 165
8.2.2.1 Dependence on instrument-specific compatibility to restrict demand 165
8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS 168
8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES 168
9 IVD QUALITY CONTROLS MARKET, BY END USER 172
9.1 INTRODUCTION 173
9.2 HOSPITALS 173
9.2.1 LARGE VOLUME OF IVD PROCEDURES PERFORMED TO DRIVE MARKET 173
9.3 CLINICAL LABORATORIES 176
9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE MARKET 176
9.4 ACADEMIC & RESEARCH INSTITUTES 179
9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO SUPPORT MARKET GROWTH 179
9.5 OTHER END USERS 182
10 IVD QUALITY CONTROLS MARKET, BY REGION 186
10.1 INTRODUCTION 187
10.2 NORTH AMERICA 187
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 192
10.2.2 US 192
10.2.2.1 High healthcare expenditure to propel market growth 192
10.2.3 CANADA 195
10.2.3.1 Government initiatives and research funding to support market growth 195
10.3 EUROPE 198
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 202
10.3.2 GERMANY 202
10.3.2.1 Rising volume of high-quality tests performed to support market growth 202
10.3.3 UK 205
10.3.3.1 Growing number of diagnostic centers to drive market 205
10.3.4 FRANCE 208
10.3.4.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market 208
10.3.5 ITALY 211
10.3.5.1 Growing disease prevalence to drive demand for better and more accurate disease diagnosis 211
10.3.6 SPAIN 213
10.3.6.1 Rising incidence of chronic diseases to support market growth 213
10.3.7 RUSSIA 216
10.3.7.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market 216
10.3.8 REST OF EUROPE 219
10.4 ASIA PACIFIC 222
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 227
10.4.2 CHINA 227
10.4.2.1 Growing access to modern healthcare and government support to boost market growth 227
10.4.3 JAPAN 230
10.4.3.1 Well-developed healthcare system and demand for improvements in quality of IVD test results to drive market 230
10.4.4 INDIA 233
10.4.4.1 Rising need to secure NABL accreditations to drive demand for quality controls 233
10.4.5 AUSTRALIA 236
10.4.5.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth 236
10.4.6 SOUTH KOREA 239
10.4.6.1 Rising healthcare expenditure and growing number of hospitals to drive market 239
10.4.7 REST OF ASIA PACIFIC 242
10.5 LATIN AMERICA 245
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 249
10.5.2 BRAZIL 249
10.5.2.1 Brazil to dominate Latin American IVD quality controls market 249
10.5.3 MEXICO 252
10.5.3.1 Increasing number of accredited clinical laboratories to support market growth 252
10.5.4 REST OF LATIN AMERICA 255
10.6 MIDDLE EAST & AFRICA 258
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 262
10.6.2 SAUDI ARABIA 262
10.6.2.1 Rising government healthcare expenditure to boost market 262
10.6.3 UAE 265
10.6.3.1 Improvements in healthcare infrastructure to support growth 265
10.6.4 REST OF MIDDLE EAST & AFRICA 268
11 COMPETITIVE LANDSCAPE 272
11.1 INTRODUCTION 272
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 272
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN IVD QUALITY CONTROLS MARKET 273
11.3 REVENUE ANALYSIS, 2022–2024 275
11.4 MARKET SHARE ANALYSIS, 2024 276
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 278
11.5.1 STARS 278
11.5.2 EMERGING LEADERS 278
11.5.3 PERVASIVE PLAYERS 278
11.5.4 PARTICIPANTS 278
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 280
11.5.5.1 Company footprint 280
11.5.5.2 Region footprint 281
11.5.5.3 Product & service footprint 282
11.5.5.4 Technology footprint 283
11.5.5.5 Manufacturer type footprint 284
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 285
11.6.1 PROGRESSIVE COMPANIES 285
11.6.2 RESPONSIVE COMPANIES 285
11.6.3 DYNAMIC COMPANIES 285
11.6.4 STARTING BLOCKS 285
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 287
11.6.5.1 Detailed list of key startups/SMEs 287
11.6.5.2 Competitive benchmarking of key emerging players/startups,
by product & service and manufacturer type 287
11.6.5.3 Competitive benchmarking of key startups/SMEs, by region 288
11.7 COMPANY VALUATION & FINANCIAL METRICS 288
11.7.1 FINANCIAL METRICS 288
11.7.2 COMPANY VALUATION 289
11.8 BRAND/PRODUCT COMPARISON 289
11.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS 289
11.9 COMPETITIVE SCENARIO 290
11.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS 290
11.9.2 DEALS 291
11.9.3 EXPANSIONS 292
12 COMPANY PROFILES 293
12.1 KEY PLAYERS 293
12.1.1 BIO-RAD LABORATORIES, INC. 293
12.1.1.1 Business overview 293
12.1.1.2 Products & services offered 294
12.1.1.3 Recent developments 299
12.1.1.3.1 Product & service launches 299
12.1.1.3.2 Deals 299
12.1.1.4 MnM view 299
12.1.1.4.1 Key strengths 299
12.1.1.4.2 Strategic choices 300
12.1.1.4.3 Weaknesses & competitive threats 300
12.1.2 THERMO FISHER SCIENTIFIC, INC. 301
12.1.2.1 Business overview 301
12.1.2.2 Products & services offered 302
12.1.2.3 Recent developments 304
12.1.2.3.1 Deals 304
12.1.2.4 MnM view 305
12.1.2.4.1 Key strengths 305
12.1.2.4.2 Strategic choices 305
12.1.2.4.3 Weaknesses & competitive threats 305
12.1.3 ABBOTT 306
12.1.3.1 Business overview 306
12.1.3.2 Products & services offered 307
12.1.3.3 MnM view 309
12.1.3.3.1 Key strengths 309
12.1.3.3.2 Strategic choices 309
12.1.3.3.3 Weaknesses & competitive threats 309
12.1.4 LGC LIMITED 310
12.1.4.1 Business overview 310
12.1.4.2 Products & services offered 311
12.1.4.3 Recent developments 314
12.1.4.3.1 Deals 314
12.1.4.4 MnM view 315
12.1.4.4.1 Key strengths 315
12.1.4.4.2 Strategic choices 315
12.1.4.4.3 Weaknesses & competitive threats 315
12.1.5 F. HOFFMANN-LA ROCHE LTD. 316
12.1.5.1 Business overview 316
12.1.5.2 Products & services offered 317
12.1.5.3 Recent developments 318
12.1.5.3.1 Deals 318
12.1.5.4 MnM view 319
12.1.5.4.1 Key strengths 319
12.1.5.4.2 Strategic choices 319
12.1.5.4.3 Weaknesses & competitive threats 319
12.1.6 RANDOX LABORATORIES LTD. 320
12.1.6.1 Business overview 320
12.1.6.2 Products & services offered 320
12.1.6.3 Recent developments 324
12.1.6.3.1 Product & service launches 324
12.1.6.3.2 Deals 324
12.1.7 SIEMENS HEALTHINEERS AG 325
12.1.7.1 Business overview 325
12.1.7.2 Products & services offered 326
12.1.8 QUIDELORTHO CORPORATION 327
12.1.8.1 Business overview 327
12.1.8.2 Products & services offered 328
12.1.8.3 Recent developments 330
12.1.8.3.1 Deals 330
12.1.8.3.2 Expansions 330
12.1.9 DANAHER CORPORATION 331
12.1.9.1 Business overview 331
12.1.9.2 Products & services offered 332
12.1.10 SYSMEX CORPORATION 334
12.1.10.1 Business overview 334
12.1.10.2 Products & services offered 335
12.1.10.3 Recent developments 336
12.1.10.3.1 Product & service launches 336
12.1.10.3.2 Deals 336
12.1.10.3.3 Expansions 337
12.1.11 BIO-TECHNE CORPORATION 339
12.1.11.1 Business overview 339
12.1.11.2 Products & services offered 340
12.1.11.3 Recent developments 344
12.1.11.3.1 Product & service launches 344
12.1.11.3.2 Deals 344
12.1.11.3.3 Expansions 345
12.1.12 MICROBIX BIOSYSTEMS INC. 346
12.1.12.1 Business overview 346
12.1.12.2 Products & services offered 347
12.1.12.3 Recent developments 348
12.1.12.3.1 Product & service launches 348
12.1.12.3.2 Deals 349
12.1.13 GRIFOLS, S.A. 351
12.1.13.1 Business overview 351
12.1.13.2 Products & services offered 352
12.1.14 MICROBIOLOGICS, INC. 353
12.1.14.1 Business overview 353
12.1.14.2 Products & services offered 353
12.1.14.3 Recent developments 355
12.1.14.3.1 Deals 355
12.1.15 ZEPTOMETRIX 356
12.1.15.1 Business overview 356
12.1.15.2 Products & services offered 356
12.1.15.3 Recent developments 357
12.1.15.3.1 Product & service launches & approvals 357
12.1.16 FORTRESS DIAGNOSTICS 359
12.1.16.1 Business overview 359
12.1.16.2 Products & services offered 359
12.2 OTHER PLAYERS 362
12.2.1 HELENA LABORATORIES CORPORATION 362
12.2.2 STRECK, INC. 363
12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC. 364
12.2.4 SUN DIAGNOSTICS, LLC 366
12.2.5 SERO AS 366
12.2.6 CONEBIOPRODUCTS 367
12.2.7 ALPHA-TEC 368
12.2.8 EUROTROL B.V. 369
12.2.9 BIOREX DIAGNOSTICS 370
13 APPENDIX 371
13.1 DISCUSSION GUIDE 371
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375
13.3 CUSTOMIZATION OPTIONS 377
13.4 RELATED REPORTS 377
13.5 AUTHOR DETAILS 378
LIST OF TABLES
TABLE 1 IVD QUALITY CONTROLS MARKET: KEY DATA FROM PRIMARY SOURCES 43
TABLE 2 IVD QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS 51
TABLE 3 NUMBER OF CANCER PATIENTS WORLDWIDE, BY REGION,
2022 VS. 2035 VS. 2045 64
TABLE 4 AVERAGE SELLING PRICING TREND OF IVD QUALITY CONTROL PRODUCTS,
2023–2025 (USD) 68
TABLE 5 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROLS, BY KEY PLAYER, 2023–2025 (USD) 69
TABLE 6 AVERAGE SELLING PRICE TREND OF IVD QUALITY CONTROL PRODUCTS,
BY REGION, 2023–2025 (USD) 70
TABLE 7 LIST OF MAJOR PATENTS, 2023–2025 72
TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY,
2020–2024 (USD MILLION) 76
TABLE 9 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY,
2020–2024 (USD MILLION) 77
TABLE 10 IMPACT OF PORTER’S FORCES ON IVD QUALITY CONTROLS MARKET 79
TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL 81
TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION 82
TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS 82
TABLE 14 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 83
TABLE 15 CLASSIFICATION OF IVD DEVICES IN EUROPE 84
TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 86
TABLE 17 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION 87
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 23 IVD QUALITY CONTROLS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 92
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS,
BY PRODUCT & SERVICE (%) 94
TABLE 25 KEY BUYING CRITERIA, BY PRODUCT & SERVICE 95
TABLE 26 RECIPROCAL TARIFF RATES ADJUSTED BY US 100
TABLE 27 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 104
TABLE 28 KEY IVD QUALITY CONTROL PRODUCTS AVAILABLE IN MARKET 105
TABLE 29 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 106
TABLE 30 IVD QUALITY CONTROL PRODUCTS MARKET, BY REGION,
2023–2030 (USD MILLION) 106
TABLE 31 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 32 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 33 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 34 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 35 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 36 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 109
TABLE 37 SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 38 NORTH AMERICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 39 EUROPE: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 40 ASIA PACIFIC: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 41 LATIN AMERICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 42 MIDDLE EAST & AFRICA: SERUM/PLASMA-BASED QUALITY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 43 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 112
TABLE 44 WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY REGION,
2023–2030 (USD MILLION) 113
TABLE 45 NORTH AMERICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 46 EUROPE: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 47 ASIA PACIFIC: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 48 LATIN AMERICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 49 MIDDLE EAST & AFRICA: WHOLE BLOOD-BASED QUALITY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 50 URINE-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 116
TABLE 51 URINE-BASED QUALITY CONTROLS MARKET, BY REGION,
2023–2030 (USD MILLION) 117
TABLE 52 NORTH AMERICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 53 EUROPE: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 54 ASIA PACIFIC: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 55 LATIN AMERICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 56 MIDDLE EAST & AFRICA: URINE-BASED QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 57 OTHER QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 120
TABLE 58 OTHER QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 59 NORTH AMERICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 60 EUROPE: OTHER QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 61 ASIA PACIFIC: OTHER QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 62 LATIN AMERICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 63 MIDDLE EAST & AFRICA: OTHER QUALITY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 64 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 123
TABLE 65 DATA MANAGEMENT SOLUTIONS MARKET, BY REGION,
2023–2030 (USD MILLION) 124
TABLE 66 NORTH AMERICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 67 EUROPE: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 68 ASIA PACIFIC: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 69 LATIN AMERICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 70 MIDDLE EAST & AFRICA: DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 71 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS 126
TABLE 72 QUALITY ASSURANCE SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 73 NORTH AMERICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 74 EUROPE: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 75 ASIA PACIFIC: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 76 LATIN AMERICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 77 MIDDLE EAST & AFRICA: QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 78 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 130
TABLE 79 QUALITY CONTROLS FOR IMMUNOASSAYS AVAILABLE IN MARKET 131
TABLE 80 IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 81 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS,
BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 82 EUROPE: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 83 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS,
BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 84 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS,
BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 85 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 86 QUALITY CONTROLS FOR CLINICAL CHEMISTRY AVAILABLE IN MARKET 135
TABLE 87 IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 88 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 89 EUROPE: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 90 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 91 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY,
BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 92 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 93 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS AVAILABLE IN MARKET 139
TABLE 94 IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 140
TABLE 95 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 96 EUROPE: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 97 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 98 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 99 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 100 QUALITY CONTROLS FOR MICROBIOLOGY AVAILABLE IN MARKET 143
TABLE 101 IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY REGION,
2023–2030 (USD MILLION) 143
TABLE 102 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 103 EUROPE: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 104 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 105 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 106 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 107 QUALITY CONTROLS FOR HEMATOLOGY AVAILABLE IN MARKET 146
TABLE 108 IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY REGION,
2023–2030 (USD MILLION) 147
TABLE 109 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 110 EUROPE: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 111 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 112 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 113 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 114 QUALITY CONTROLS FOR COAGULATION & HEMOSTASIS AVAILABLE IN MARKET 150
TABLE 115 IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 116 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 117 EUROPE: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS,
BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 118 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 119 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 120 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 121 QUALITY CONTROLS FOR OTHER TECHNOLOGIES AVAILABLE IN MARKET 154
TABLE 122 IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2023–2030 (USD MILLION) 154
TABLE 123 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 124 EUROPE: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 125 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 126 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 127 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 128 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 158
TABLE 129 KEY THIRD-PARTY CONTROLS AVAILABLE IN MARKET 159
TABLE 130 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 131 THIRD-PARTY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 132 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 160
TABLE 133 EUROPE: THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 160
TABLE 134 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 161
TABLE 135 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 161
TABLE 136 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 161
TABLE 137 INDEPENDENT THIRD-PARTY CONTROLS AVAILABLE IN MARKET 162
TABLE 138 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY REGION,
2023–2030 (USD MILLION) 163
TABLE 139 NORTH AMERICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 140 EUROPE: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 164
TABLE 141 ASIA PACIFIC: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 142 LATIN AMERICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 143 MIDDLE EAST & AFRICA: INDEPENDENT THIRD-PARTY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 144 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS AVAILABLE IN MARKET 166
TABLE 145 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY REGION,
2023–2030 (USD MILLION) 166
TABLE 146 NORTH AMERICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 147 EUROPE: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET,
2023–2030 (USD MILLION) 167
TABLE 148 ASIA PACIFIC: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 149 LATIN AMERICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 150 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 151 OEM CONTROLS AVAILABLE IN MARKET 169
TABLE 152 OEM CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 170
TABLE 153 NORTH AMERICA: OEM CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 170
TABLE 154 EUROPE: OEM CONTROLS MARKET, 2023–2030 (USD MILLION) 170
TABLE 155 ASIA PACIFIC: OEM CONTROLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 156 LATIN AMERICA: OEM CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 171
TABLE 157 MIDDLE EAST & AFRICA: OEM CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 171
TABLE 158 IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 173
TABLE 159 IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 174
TABLE 160 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 161 EUROPE: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 175
TABLE 162 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 163 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 164 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 165 IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 177
TABLE 166 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 167 EUROPE: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 168 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 169 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 170 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 171 IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023–2030 (USD MILLION) 180
TABLE 172 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 180
TABLE 173 EUROPE: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 174 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 175 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 176 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 177 IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 183
TABLE 178 NORTH AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 183
TABLE 179 EUROPE: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 180 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 181 LATIN AMERICA: IVD QUALITY CONTROLS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 182 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET FOR OTHER
END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 183 IVD QUALITY CONTROLS MARKET, BY REGION, 2023–2030 (USD MILLION) 187
TABLE 184 NORTH AMERICA: MACROECONOMIC INDICATORS 189
TABLE 185 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 189
TABLE 186 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 189
TABLE 187 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 188 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 190
TABLE 189 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 191
TABLE 190 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 191 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 191
TABLE 192 US: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 193
TABLE 193 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 194 US: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 194
TABLE 195 US: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 194
TABLE 196 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 197 US: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 195
TABLE 198 US: NUMBER OF IN VITRO DIAGNOSTICS TESTS CONDUCTED,
2022–2030 (BILLION) 195
TABLE 199 CANADA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 196
TABLE 200 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 201 CANADA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 197
TABLE 202 CANADA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 197
TABLE 203 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 204 CANADA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 198
TABLE 205 EUROPE: MACROECONOMIC INDICATORS 199
TABLE 206 EUROPE: IVD QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 199
TABLE 207 EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 199
TABLE 208 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 200
TABLE 209 EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 200
TABLE 210 EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 201
TABLE 211 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 212 EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 201
TABLE 213 GERMANY: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 203
TABLE 214 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 215 GERMANY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 204
TABLE 216 GERMANY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 204
TABLE 217 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 204
TABLE 218 GERMANY: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 205
TABLE 219 UK: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 206
TABLE 220 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 221 UK: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 206
TABLE 222 UK: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 207
TABLE 223 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 224 UK: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 207
TABLE 225 FRANCE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 208
TABLE 226 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 227 FRANCE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 209
TABLE 228 FRANCE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 210
TABLE 229 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 230 FRANCE: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 210
TABLE 231 ITALY: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 211
TABLE 232 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 212
TABLE 233 ITALY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 212
TABLE 234 ITALY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 212
TABLE 235 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 236 ITALY: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 213
TABLE 237 SPAIN: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 214
TABLE 238 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 239 SPAIN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 215
TABLE 240 SPAIN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 215
TABLE 241 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 242 SPAIN: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 216
TABLE 243 RUSSIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 217
TABLE 244 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 217
TABLE 245 RUSSIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 218
TABLE 246 RUSSIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 218
TABLE 247 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 248 RUSSIA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 219
TABLE 249 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 220
TABLE 250 REST OF EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 251 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 221
TABLE 252 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 221
TABLE 253 REST OF EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 254 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 222
TABLE 255 ASIA PACIFIC: MACROECONOMIC INDICATORS 223
TABLE 256 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 224
TABLE 257 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 224
TABLE 258 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 259 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 225
TABLE 260 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 226
TABLE 261 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 262 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 226
TABLE 263 CHINA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 228
TABLE 264 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 265 CHINA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 229
TABLE 266 CHINA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 229
TABLE 267 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 268 CHINA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 230
TABLE 269 JAPAN: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 231
TABLE 270 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 231
TABLE 271 JAPAN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 232
TABLE 272 JAPAN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 232
TABLE 273 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 274 JAPAN: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 233
TABLE 275 INDIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 234
TABLE 276 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 277 INDIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 235
TABLE 278 INDIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 235
TABLE 279 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 280 INDIA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 236
TABLE 281 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 237
TABLE 282 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 237
TABLE 283 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 238
TABLE 284 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 238
TABLE 285 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 286 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 239
TABLE 287 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 240
TABLE 288 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 289 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 241
TABLE 290 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 241
TABLE 291 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 292 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 242
TABLE 293 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 243
TABLE 294 REST OF ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 295 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 244
TABLE 296 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET,
BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 244
TABLE 297 REST OF ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 298 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 245
TABLE 299 LATIN AMERICA: MACROECONOMIC INDICATORS 246
TABLE 300 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 246
TABLE 301 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 246
TABLE 302 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 303 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 247
TABLE 304 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 248
TABLE 305 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 306 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 248
TABLE 307 BRAZIL: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 250
TABLE 308 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 309 BRAZIL: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 251
TABLE 310 BRAZIL: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 251
TABLE 311 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251
TABLE 312 BRAZIL: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 252
TABLE 313 MEXICO: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 253
TABLE 314 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 253
TABLE 315 MEXICO: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 254
TABLE 316 MEXICO: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 254
TABLE 317 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 318 MEXICO: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 255
TABLE 319 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET,
BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 256
TABLE 320 REST OF LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 321 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 257
TABLE 322 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 257
TABLE 323 REST OF LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 324 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 258
TABLE 325 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 259
TABLE 326 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 259
TABLE 327 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET,
BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 259
TABLE 328 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 329 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 260
TABLE 330 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET,
BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 261
TABLE 331 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 332 MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 261
TABLE 333 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 263
TABLE 334 SAUDI ARABIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 263
TABLE 335 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 264
TABLE 336 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 264
TABLE 337 SAUDI ARABIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2023–2030 (USD MILLION) 264
TABLE 338 SAUDI ARABIA: IVD QUALITY CONTROLS MARKET, BY END USER,
2023–2030 (USD MILLION) 265
TABLE 339 UAE: IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 266
TABLE 340 UAE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 341 UAE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 267
TABLE 342 UAE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2023–2030 (USD MILLION) 267
TABLE 343 UAE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 344 UAE: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 268
TABLE 345 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET,
BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 269
TABLE 346 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 347 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 270
TABLE 348 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET,
BY MANUFACTURER TYPE, 2023–2030 (USD MILLION) 270
TABLE 349 REST OF MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 350 REST OF MIDDLE EAST & AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2023–2030 (USD MILLION) 271
TABLE 351 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN IVD QUALITY CONTROLS MARKET, JANUARY 2021−AUGUST 2025 273
TABLE 352 IVD QUALITY CONTROLS MARKET: DEGREE OF COMPETITION 276
TABLE 353 IVD QUALITY CONTROLS MARKET: REGION FOOTPRINT 281
TABLE 354 IVD QUALITY CONTROLS MARKET: PRODUCT & SERVICE FOOTPRINT 282
TABLE 355 IVD QUALITY CONTROLS MARKET: TECHNOLOGY FOOTPRINT 283
TABLE 356 IVD QUALITY CONTROLS MARKET: MANNUFACTURER TYPE FOOTPRINT 284
TABLE 357 IVD QUALITY CONTROLS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 287
TABLE 358 IVD QUALITY CONTROLS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT & SERVICE AND
MANUFACTURER TYPE 287
TABLE 359 IVD QUALITY CONTROLS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION 288
TABLE 360 IVD QUALITY CONTROLS MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025 290
TABLE 361 IVD QUALITY CONTROLS MARKET: DEALS, JANUARY 2021–AUGUST 2025 291
TABLE 362 IVD QUALITY CONTROLS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025 292
TABLE 363 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 293
TABLE 364 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 294
TABLE 365 BIO-RAD LABORATORIES, INC.: PRODUCT & SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2025 299
TABLE 366 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2025 299
TABLE 367 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 301
TABLE 368 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 302
TABLE 369 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025 304
TABLE 370 ABBOTT: COMPANY OVERVIEW 306
TABLE 371 ABBOTT: PRODUCTS & SERVICES OFFERED 307
TABLE 372 LGC LIMITED: COMPANY OVERVIEW 310
TABLE 373 LGC LIMITED: PRODUCTS & SERVICES OFFERED 311
TABLE 374 LGC LIMITED: DEALS, JANUARY 2021–AUGUST 2025 314
TABLE 375 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 316
TABLE 376 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES OFFERED 317
TABLE 377 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2025 318
TABLE 378 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW 320
TABLE 379 RANDOX LABORATORIES LTD.: PRODUCTS & SERVICES OFFERED 320
TABLE 380 RANDOX LABORATORIES LTD.: PRODUCT & SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2025 324
TABLE 381 RANDOX LABORATORIES LTD.: DEALS, JANUARY 2021–AUGUST 2025 324
TABLE 382 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 325
TABLE 383 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED 326
TABLE 384 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 327
TABLE 385 QUIDELORTHO CORPORATION: PRODUCTS & SERVICES OFFERED 328
TABLE 386 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 330
TABLE 387 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025 330
TABLE 388 DANAHER CORPORATION: COMPANY OVERVIEW 331
TABLE 389 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED 332
TABLE 390 SYSMEX CORPORATION: COMPANY OVERVIEW 334
TABLE 391 SYSMEX CORPORATION: PRODUCTS & SERVICES OFFERED 335
TABLE 392 SYSMEX CORPORATION: PRODUCT & SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2025 336
TABLE 393 SYSMEX CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 336
TABLE 394 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025 337
TABLE 395 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW 339
TABLE 396 BIO-TECHNE CORPORATION: PRODUCTS & SERVICES OFFERED 340
TABLE 397 BIO-TECHNE CORPORATION: PRODUCT & SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2025 344
TABLE 398 BIO-TECHNE CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 344
TABLE 399 BIO-TECHNE CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025 345
TABLE 400 MICROBIX BIOSYSTEMS INC.: COMPANY OVERVIEW 346
TABLE 401 MICROBIX BIOSYSTEMS INC.: PRODUCTS & SERVICES OFFERED 347
TABLE 402 MICROBIX BIOSYSTEMS INC.: PRODUCT & SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2025 348
TABLE 403 MICROBIX BIOSYSTEMS INC.: DEALS, JANUARY 2021–AUGUST 2025 349
TABLE 404 GRIFOLS, S.A.: COMPANY OVERVIEW 351
TABLE 405 GRIFOLS, S.A.: PRODUCTS & SERVICES OFFERED 352
TABLE 406 MICROBIOLOGICS, INC.: COMPANY OVERVIEW 353
TABLE 407 MICROBIOLOGICS, INC.: PRODUCTS & SERVICES OFFERED 353
TABLE 408 MICROBIOLOGICS, INC.: DEALS, JANUARY 2021–AUGUST 2025 355
TABLE 409 ZEPTOMETRIX: COMPANY OVERVIEW 356
TABLE 410 ZEPTOMETRIX: PRODUCTS & SERVICES OFFERED 356
TABLE 411 ZEPTOMETRIX: PRODUCT & SERVICE LAUNCHES & APPROVALS,
JANUARY 2021–AUGUST 2025 357
TABLE 412 FORTRESS DIAGNOSTICS: COMPANY OVERVIEW 359
TABLE 413 FORTRESS DIAGNOSTICS: PRODUCTS & SERVICES OFFERED 359
TABLE 414 HELENA LABORATORIES CORPORATION: COMPANY OVERVIEW 362
TABLE 415 STRECK, INC.: COMPANY OVERVIEW 363
TABLE 416 MAINE MOLECULAR QUALITY CONTROLS, INC.: COMPANY OVERVIEW 364
TABLE 417 SUN DIAGNOSTICS, LLC: COMPANY OVERVIEW 366
TABLE 418 SERO AS: COMPANY OVERVIEW 366
TABLE 419 CONEBIOPRODUCTS: COMPANY OVERVIEW 367
TABLE 420 ALPHA-TEC: COMPANY OVERVIEW 368
TABLE 421 EUROTROL B.V.: COMPANY OVERVIEW 369
TABLE 422 BIOREX DIAGNOSTICS: COMPANY OVERVIEW 370
LIST OF FIGURES
FIGURE 1 IVD QUALITY CONTROLS MARKET SEGMENTATION & REGIONAL SCOPE 35
FIGURE 2 IVD QUALITY CONTROLS MARKET: RESEARCH DESIGN METHODOLOGY 39
FIGURE 3 PRIMARY SOURCES 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 44
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 45
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 46
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
FIGURE 8 IVD QUALITY CONTROLS MARKET: TOP-DOWN APPROACH 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 49
FIGURE 10 IVD QUALITY CONTROLS MARKET: RESEARCH ASSUMPTIONS 50
FIGURE 11 IVD QUALITY CONTROLS MARKET, BY PRODUCT & SERVICE,
2025 VS. 2030 (USD MILLION) 52
FIGURE 12 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 53
FIGURE 13 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE,
2025 VS. 2030 (USD MILLION) 54
FIGURE 14 IVD QUALITY CONTROLS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54
FIGURE 15 IVD QUALITY CONTROLS MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 55
FIGURE 16 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET 56
FIGURE 17 QUALITY CONTROL PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 57
FIGURE 18 IMMUNOASSAYS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD 57
FIGURE 19 THIRD-PARTY CONTROLS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 58
FIGURE 20 HOSPITALS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030 58
FIGURE 21 NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING
FORECAST PERIOD 59
FIGURE 22 IVD QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 60
FIGURE 23 NUMBER OF CLIA-ACCREDITED LABORATORIES, BY ACCREDITATION ORGANIZATION (2024) 61
FIGURE 24 PATENT ANALYSIS FOR QUALITY CONTROLS FOR DIAGNOSTICS,
JANUARY 2015–DECEMBER 2024 71
FIGURE 25 IVD QUALITY CONTROLS MARKET: VALUE CHAIN ANALYSIS 73
FIGURE 26 IVD QUALITY CONTROLS MARKET: SUPPLY CHAIN ANALYSIS 75
FIGURE 27 IVD QUALITY CONTROLS MARKET: ECOSYSTEM ANALYSIS 77
FIGURE 28 IVD QUALITY CONTROLS MARKET: PORTER’S FIVE FORCES ANALYSIS 79
FIGURE 29 IVD QUALITY CONTROLS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE 94
FIGURE 31 KEY BUYING CRITERIA, BY PRODUCT & SERVICE 94
FIGURE 32 NUMBER OF DEALS & FUNDING ACTIVITIES IN IVD QUALITY CONTROLS MARKET 95
FIGURE 33 MARKET POTENTIAL OF AI IN IVD QUALITY CONTROLS MARKET 97
FIGURE 34 NORTH AMERICA: IVD QUALITY CONTROLS MARKET SNAPSHOT 188
FIGURE 35 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET SNAPSHOT 223
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN IVD QUALITY CONTROLS MARKET
(2022–2024) 275
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IVD QUALITY CONTROLS MARKET (2024) 276
FIGURE 38 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 279
FIGURE 39 IVD QUALITY CONTROLS MARKET: COMPANY FOOTPRINT 280
FIGURE 40 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 286
FIGURE 41 EV/EBITDA OF KEY VENDORS 288
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 289
FIGURE 43 IVD QUALITY CONTROLS MARKET: BRAND COMPARISON 289
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 294
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 302
FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2024) 307
FIGURE 47 LGC LIMITED: COMPANY SNAPSHOT (2023) 311
FIGURE 48 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 317
FIGURE 49 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 326
FIGURE 50 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2024) 328
FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 332
FIGURE 52 SYSMEX CORPORATION: COMPANY SNAPSHOT (2024) 335
FIGURE 53 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2024) 340
FIGURE 54 MICROBIX BIOSYSTEMS INC.: COMPANY SNAPSHOT (2024) 347
FIGURE 55 GRIFOLS, S.A.: COMPANY SNAPSHOT (2024) 352
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11